Antibe Therapeutics Inc.
ATBPF
$0.2156
$0.025613.47%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -3.10M | -3.73M | -4.31M | -2.62M | -3.18M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 324.10K | -58.90K | 309.70K | 518.30K | 654.20K |
| Change in Net Operating Assets | -53.70K | -1.00M | 585.10K | -397.00K | -129.70K |
| Cash from Operations | -2.83M | -4.80M | -3.41M | -2.50M | -2.66M |
| Capital Expenditure | -- | -- | -- | 1.50K | -8.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 643.20K | -- | -- | -177.40K | 411.80K |
| Other Investing Activities | 7.47M | 1.33M | 4.93M | -229.90K | -11.80K |
| Cash from Investing | 8.12M | 1.33M | 4.93M | -405.90K | 391.90K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -1.00K | 0.00 |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 160.00K | -1.00K |
| Cash from Financing | -- | -- | -- | 117.60K | -700.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.29M | -3.47M | 1.52M | -2.79M | -2.26M |
